RGNX Chart
- 52-Week Range: $19.35 - $45.68
- Market Capitalization: $810.92M
- Short Percentage: 0%
- Target Price: $51.33
- Shares Outstanding: 43.13M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
RGNX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- REGENXBIO Inc. (RGNX) CEO Ken Mills on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 4th
- REGENXBIO's (RGNX) CEO Ken Mills on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 1st
Company Info
Website: https://www.regenxbio.com
Address: 9804 Medical Center Drive, Rockville, MD, United States, 20850
Sector: Healthcare
Industry: Biotechnology
Full time employees: 372
Address: 9804 Medical Center Drive, Rockville, MD, United States, 20850
Sector: Healthcare
Industry: Biotechnology
Full time employees: 372
$RGNX just added more
$RGNX bought more
$RGNX let’s go down baby 😉
$RGNX whelp. you win this round. goodluck
$RGNX who else excited??
$RGNX what time we going green?
$RGNX See ya Monday
$RGNX unstoppable up wow
$RGNX Lol she wants higher
$RGNX the redness has arrived